Metesind glucuronate
Alternative Names: AG 331; AG 341Latest Information Update: 21 Sep 2006
At a glance
- Originator Agouron Pharmaceuticals
- Class Small molecules
- Mechanism of Action Thymidylate synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Brain cancer; Solid tumours
Most Recent Events
- 21 Sep 2006 Discontinued - Phase-I for Solid tumours in USA (IV-infusion)
- 22 Jun 2000 Warner-Lambert has merged with Pfizer
- 19 Jan 2000 Phase-I clinical trials for Solid tumours in USA (IV-infusion)